ワクチン技術の世界市場

Report Highlights

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Summary:

The global market for vaccine technologies was worth $REDACTED billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion through 2028. Growth in the vaccine market is anticipated on the basis of technological advancements. Advancements will occur in regard to the development of novel vaccines towards emerging infectious diseases, cancers and allergies. Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth.

The global vaccine technologies market is segmented in this report by technology, disease, age, and region.

Report Scope:

This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.

This report includes only human vaccines; animal vaccines have not been considered in this report.

This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.

Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.

The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines.

This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.

This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.

Report Synopsis

Report Includes:

• 34 data tables and 63 additional tables
• An up-to-date overview of the global markets for vaccine technologies
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and region
• Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscape
• Assessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization schedule
• Discussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companies
• Review of patents and patent applications
• Overview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture funding
• Analysis of the competitive landscape based on recent developments and segmental revenues
• Profiles of the leading companies

Table of Contents
Chapter 1 Introduction
Study Background
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What’s New in This Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Insights
Chapter 3 Market and Technology Background
Definitions
Immune System and Vaccines
Components of the Immune System
Cells of the Immune System
Immune Response
Major Histocompatibility Complex (MHC)
Immunization and Vaccines
Disorders of the Immune System
Impact of Lifestyle on the Immune System
How Vaccines Work
Principles of Immunization
Types of Immunity
Advantages of Vaccination
History of Vaccines
Vaccines and Immunization, Overview
Types of Vaccines
Attenuated (Live) Vaccines
Inactivated (Killed) Vaccines
Toxoid Vaccines
Subunit Vaccines
Conjugate Vaccines
Recombinant Vector Vaccines
DNA Vaccines
RNA Vaccines
Immunization
Advantages of Immunization
Adjuvants and Excipients
Pathogen Components
Particulate Adjuvants
Infectious Diseases Preventable by Vaccine
Human Diseases
Viral Diseases
Bacterial Diseases
Regulatory Aspects
World Health Organization (WHO) Prequalified Vaccines
New Product Approvals
Recalls
Significant Regulatory Developments in Vaccines
Chapter 4 Market Dynamics
Overview
Market Drivers
Growing Awareness of Immunization
Growing Investments and R&D
New Vaccines
Prevalence of Infectious Diseases
Market Restraints
Vaccine Development and Pricing
Market Opportunities
Increased Demand from Emerging Markets
Therapeutic Vaccines
Chapter 5 Global Market for COVID-19 Vaccines
Overview
COVID-19 Vaccine Technologies
Advent of mRNA Technology
Impact of COVID-19 on Routine Infant Vaccination
COVID-19 Disruptions
Stagnating Global Coverage Rate
Progress and Challenges by Country and Region
Chapter 6 Market Breakdown by Technology
Global Market for Vaccine Technologies by Technology
Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
Live-Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Other/Combination Vaccines
Chapter 7 Market Breakdown by Disease
Global Market for Vaccine Technologies by Disease
Pneumococcal
Diphtheria and Tetanus
HPV
MMR
Others
Chapter 8 Market Breakdown by Age Group
Global Market for Vaccine Technologies by Age Group Treated
Pediatrics
Adolescents and Adults
Chapter 9 Market Breakdown by Region
Global Market for Vaccine Technologies by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 10 Emerging Technologies and Developments
Developments
mRNA Vaccines
Viral Vector Vaccines
Nanoparticle Vaccines
DNA Vaccines
Virus-Like Particle (VLP) Vaccines
Self-Amplifying RNA Vaccines
Innovative Adjuvants
AI and Computational Biology
Personalized Vaccines
Plant-Based Vaccines
Chapter 11 Competitive Landscape
Competitive Landscape
Company Share Analysis
Chapter 12 Company Profiles
ABBOTT
ASTRAZENECA
BAVARIAN NORDIC
BHARAT BIOTECH INTERNATIONAL LTD.
EMERGENT BIOSOLUTIONS INC.
GSK PLC.
JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.
MITSUBISHI TANABE PHARMA CORP.
PANACEA BIOTEC LTD.
PFIZER INC.
SANOFI
Chapter 13 Appendix: List of Acronyms
Acronyms

List of Tables
Summary Table A : Global Market for Vaccine Technologies, by Vaccine Type, Through 2028
Summary Table B : Global Market for COVID-19 Vaccines, 2019-2028
Table 1 : History of Vaccines
Table 2 : Types of Attenuated (Live) Vaccines
Table 3 : Pros and Cons of Attenuated (Live) Vaccines
Table 4 : Types of Inactivated (Killed) Vaccines
Table 5 : Pros and Cons of Inactivated (Killed) Vaccines
Table 6 : Types of Toxoid Vaccines
Table 7 : Pros and Cons of Toxoid Vaccines
Table 8 : Types of Subunit Vaccines
Table 9 : Pros and Cons of Subunit Vaccines
Table 10 : Types of Conjugate Vaccines
Table 11 : Pros and Cons of Conjugate Vaccines
Table 12 : Types of Recombinant Vector Vaccines, by Segment
Table 13 : Pros and Cons of Recombinant Vector Vaccines
Table 14 : Types of DNA Vaccines, by Segment
Table 15 : Pros and Cons of DNA Vaccines
Table 16 : Pros and Cons of RNA Vaccines
Table 17 : Vaccine Excipient and Media Summary, Excipients included in U.S. Vaccines
Table 18 : Vaccine-Preventable Human Viral Diseases
Table 19 : Vaccine-Preventable Human Bacterial Diseases
Table 20 : WHO Prequalified Vaccines, Feb. 2018–April 2020
Table 21 : Newly Approved Vaccines, Dec. 2018–April 2020
Table 22 : Emerging Viral Infectious Diseases, 1900-2020
Table 23 : Global Market for COVID-19 Vaccines, 2019-2028
Table 24 : WHO-Approved COVID-19 Vaccines: Companies and Technology Adopted
Table 25 : COVID-19 Vaccines in the Pipeline
Table 26 : Global Market for Vaccine Technologies, by Vaccine Type , Through 2028
Table 27 : Global Market for Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, by Region, Through 2028
Table 28 : Global Market for Live-Attenuated Vaccines, by Region, Through 2028
Table 29 : Global Market for Inactivated Vaccines, by Region, Through 2028
Table 30 : Global Market for Toxoid Vaccines, by Region, Through 2028
Table 31 : Global Market for Other/Combination Vaccines, by Region, Through 2028
Table 32 : Vaccines, by Disease Type
Table 33 : Global Market for Vaccine Technologies, by Disease Type, Through 2028
Table 34 : Global Market for Vaccine Technologies for Pneumococcal Disease, by Region, Through 2028
Table 35 : Global Market for Vaccine Technologies for Diphtheria and Tetanus, by Region, Through 2028
Table 36 : Global Market for Vaccine Technologies for HPV, by Region, Through 2028
Table 37 : Global Market for Vaccine Technologies for MMR, by Region, Through 2028
Table 38 : Seasonal Influenza Vaccines
Table 39 : Global Market for Vaccine Technologies for Other Disease Segments, by Region, Through 2028
Table 40 : Global Market for Vaccine Technologies, by Age Group, Through 2028
Table 41 : Pediatric Vaccine Doses
Table 42 : Pediatric/VFC Vaccine Price List, 2019
Table 43 : Influenza Vaccine Price List, 2020
Table 44 : Global Market for Vaccine Technologies for Pediatrics, by Region, Through 2028
Table 45 : Price List of Vaccines for Adolescents and Adults
Table 46 : Global Market for Vaccines for Adolescents and Adults, by Region, Through 2028
Table 47 : Global Market for Vaccine Technologies, by Region, Through 2028
Table 48 : North American Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 49 : North American Market for Vaccine Technologies, by Country, Through 2028
Table 50 : Immunization Schedule, Canada, 2020
Table 51 : European Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 52 : European Market for Vaccine Technologies, by Country, Through 2028
Table 53 : Immunization Schedule, Germany, 2020
Table 54 : Immunization Schedule, France, 2020
Table 55 : Vaccination and Immunization Schedule, U.K., 2020
Table 56 : Immunization Schedule, Italy, 2020
Table 57 : Asia-Pacific Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 58 : Asia-Pacific Market for Vaccine Technologies, by Country, Through 2028
Table 59 : Immunization Schedule, China, 2020
Table 60 : Immunization Schedule, Japan, 2020
Table 61 : Immunization Schedule, India, 2020
Table 62 : GAVI Support to India, 2001-2021
Table 63 : Vaccination Coverage Estimates, Middle East and North Africa, 2014-2020
Table 64 : Vaccination Coverage, Latin America, and Caribbean, 2014-2020
Table 65 : RoW Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 66 : RoW Market for Vaccine Technologies, by Sub-Region, Through 2028
Table 67 : Abbott: Company Snapshot
Table 68 : Abbott Laboratories: Financial Performance, 2022
Table 69 : Astrazeneca: Company Snapshot
Table 70 : AstraZeneca: Vaccines
Table 71 : AstraZeneca: Recent Developments, 2021
Table 72 : Bavarian Nordic: Company Snapshot
Table 73 : Bavarian Nordic: Recent Developments, 2021
Table 74 : Bharat Biotech: Company Snapshot
Table 75 : Bharat Biotech: Vaccines
Table 76 : Bharat Biotech: Recent Developments, 2020 and 2021
Table 77 : Emergent BioSolutions: Company Snapshot
Table 78 : Emergent BioSolutions: Vaccines
Table 79 : Emergent BioSolutions: Recent Developments, 2020 and 2021
Table 80 : GSK Plc: Company Snapshot
Table 81 : GSK Plc: Vaccines Offered
Table 82 : GSK Plc.: Recent Developments, 2020 and 2021
Table 83 : Johnson & Johnson: Company Snapshot
Table 84 : Johnson & Johnson: Recent Developments, 2021
Table 85 : Merck & Co. Inc.: Company Snapshot
Table 86 : Merck & Co. Inc.: Vaccines
Table 87 : Merck & Co. Inc.: Recent Developments, 2020 and 2021
Table 88 : Mitsubishi Tanabe Pharma Corp.: Company Snapshot
Table 89 : Panacea Biotec Ltd.: Company Snapshot
Table 90 : Pfizer Inc.: Company Snapshot
Table 91 : Pfizer Inc.: Recent Developments, 2020 and 2021
Table 92 : Sanofi: Company Snapshot
Table 93 : Sanofi: Vaccines
Table 94 : Sanofi: Recent Developments, 2021
Table 95 : Acronyms Used in This Report

List of Figures
Summary Figure A : Global Market for Vaccine Technologies, by Vaccine Type, 2022-2028
Summary Figure B : Global Market for COVID-19 Vaccines, 2019-2028
Figure 1 : Global Markets for Vaccine Technologies Market Dynamics
Figure 2 : Global Market Share of COVID-19 Vaccines, by Technology, 2022
Figure 3 : Global Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 4 : Global Market for Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2020-2028
Figure 5 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, by Region, 2020-2028
Figure 6 : Global Market for Live-Attenuated Vaccines, 2020-2028
Figure 7 : Global Market for Live-Attenuated Vaccines, by Region, 2020-2028
Figure 8 : Global Market for Inactivated Vaccines, 2020-2028
Figure 9 : Global Market for Inactivated Vaccines, by Region, 2020-2028
Figure 10 : Global Market for Toxoid Vaccines, 2020-2028
Figure 11 : Global Market for Toxoid Vaccines, by Region, 2020-2028
Figure 12 : Global Market for Other/Combination Vaccines, 2020-2028
Figure 13 : Global Market for Other/Combination Vaccines, by Region, 2020-2028
Figure 14 : Global Market Share of Vaccine Technologies, by Disease Type, 2022
Figure 15 : Global Market for Vaccine Technologies for Pneumococcal Disease, 2020-2028
Figure 16 : Global Market for Vaccine Technologies for Pneumococcal Disease, by Region, 2020-2028
Figure 17 : Global Market for Vaccine Technologies for Diphtheria and Tetanus, 2020-2028
Figure 18 : Global Market for Vaccine Technologies for Diphtheria and Tetanus, by Region, 2020-2028
Figure 19 : Global Market for Vaccine Technologies for HPV, 2020-2028
Figure 20 : Global Market for Vaccine Technologies for HPV, by Region, 2020-2028
Figure 21 : Global Market for Vaccine Technologies for MMR, 2020-2028
Figure 22 : Global Market for Vaccine Technologies for MMR, by Region, 2020-2028
Figure 23 : Global Market for Vaccine Technologies for Other Disease Segments, 2020-2028
Figure 24 : Global Market for Vaccine Technologies for Other Disease Segments, by Region, 2020-2028
Figure 25 : Global Market Share of Vaccine Technologies, by Age Group, 2022
Figure 26 : Global Market for Vaccine Technologies for Pediatrics, 2020-2028
Figure 27 : Global Market for Vaccine Technologies for Pediatrics, by Region, 2020-2028
Figure 28 : Global Market for Vaccines for Adolescents and Adults, 2020-2028
Figure 29 : Global Market for Vaccines for Adolescents and Adults, by Region, 2020-2028
Figure 30 : Global Market for Vaccine Technologies, by Region, 2020-2028
Figure 31 : Global Market Share of Vaccine Technologies, by Region, 2022
Figure 32 : North American Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 33 : North American Market Share for Vaccine Technologies, by Country, 2022
Figure 34 : U.S. Market for Vaccine Technologies, 2020-2028
Figure 35 : Canadian Market for Vaccine Technologies, 2020-2028
Figure 36 : European Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 37 : European Market Share for Vaccine Technologies, by Country, 2022
Figure 38 : German Market for Vaccine Technologies, 2020-2028
Figure 39 : Russian Market for Vaccine Technologies, 2020-2028
Figure 40 : French Market for Vaccine Technologies, 2020-2028
Figure 41 : U.K. Market for Vaccine Technologies, 2020-2028
Figure 42 : Italian Market for Vaccine Technologies, 2020-2028
Figure 43 : Spanish Market for Vaccine Technologies, 2020-2028
Figure 44 : Rest of the European Market for Vaccine Technologies, 2020-2028
Figure 45 : Asia-Pacific Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 46 : Asia-Pacific Market Share for Vaccine Technologies, by Country, 2022
Figure 47 : Chinese Market for Vaccine Technologies, 2020-2028
Figure 48 : RoW Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 49 : RoW Market Share for Vaccine Technologies, by Sub-Region, 2022
Figure 50 : Global Market Share for Vaccine Technologies, by Company, 2022
Figure 51 : Abbott Laboratories: Financial Performance, 2021 and 2022
Figure 52 : Abbott Laboratories: Revenue Share, by Business Unit, 2022
Figure 53 : Abbott Laboratories: Revenue Share, by County/Region, 2022
Figure 54 : AstraZeneca: Net Revenue, 2016-2020
Figure 55 : AstraZeneca: Revenue Share, by Business Segment, 2020
Figure 56 : AstraZeneca: Revenue Share, by Region/Country, 2020
Figure 57 : Bavarian Nordic: Net Revenue, 2016-2020
Figure 58 : Bavarian Nordic: Revenue Share, by Country, 2020
Figure 59 : Emergent BioSolutions: Net Revenue, 2016-2020
Figure 60 : GSK Plc: Net Revenue, 2016-2020
Figure 61 : GSK Plc: Revenue Share, by Business Segment, 2020
Figure 62 : GSK Plc: Revenue Share, by Region, 2020
Figure 63 : Johnson & Johnson: Net Revenue, 2016-2020
Figure 64 : Johnson & Johnson: Revenue Share, by Business Segment, 2020
Figure 65 : Johnson & Johnson: Revenue Share, by Country/Region, 2020
Figure 66 : Merck & Co. Inc.: Net Revenue, 2016-2020
Figure 67 : Merck & Co. Inc.: Revenue Share, by Business Segment, 2020
Figure 68 : Merck & Co. Inc.: Revenue Share, by Region/Country, 2021
Figure 69 : Panacea Biotec Ltd.: Net Revenue, 2018-2022
Figure 70 : Panacea Biotec Ltd.: Revenue Share, by Business Segment, 2022
Figure 71 : Panacea Biotec Ltd.: Revenue Share, by Country/Region, 2022
Figure 72 : Pfizer Inc.: Net Revenue, 2020-2022
Figure 73 : Pfizer Inc.: Revenue Share, by Region/Country, 2022
Figure 74 : Sanofi: Net Revenue, 2017-2021
Figure 75 : Sanofi: Revenue Share, by Business Segment, 2020
Figure 76 : Sanofi: Revenue Share, by Region, 2021